Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,001 public trials 2,038 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Active, not recruiting

Ibrutinib + Venetoclax in Untreated WM

NCT04273139

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Active, not recruiting

Study of Belantamab Mafodotin in Combination With Kd for the Treatment of Relapsed Myeloma Patients, Refractory to Lenalidomide

NCT05060627

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Hospital Germans Trias i Pujol (ICO BADALONA) Badalona, Spain
  • Hospital Clinic Barcelona, Spain
  • ICO Duran i Reynals L'Hospitalet de Llobregat, Spain
  • H. Gregorio Marañón Madrid, Spain
View all 15 locations
View Trial Details
Active, not recruiting

A Trial to Learn How Effective and Safe Odronextamab is Compared to Standard of Care for Adult Participants With Previously Treated Aggressive B-cell Non-Hodgkin Lymphoma

NCT06230224

Conditions
B-cell Non-Hodgkin Lymphoma (B-NHL), Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • Hospital Aleman Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina
  • Hospital Britanico de Buenos Aires Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina
  • Instituto Alexander Fleming Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina
  • Fundaleu - Fundacion Para Combatir La Leucemia Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina
View all 81 locations
View Trial Details
Active, not recruiting

A Rollover Study of CC-122

NCT05688475

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +27 more
Locations
  • Local Institution - 100 New York, United States
  • Local Institution - 101 Nashville, Tennessee, United States
  • Local Institution - 102 Madison, Wisconsin, United States
  • Local Institution - 300 Bordeaux, France
View Trial Details
Active, not recruiting

Tafasitamab and Zanubrutinib for the Treatment of Patients With Newly Diagnosed Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma, TaZA CLL Study

NCT05718869

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • City of Hope at Irvine Lennar Irvine, California, United States
  • University of Miami Sylvester Comprehensive Cancer Center Miami, Florida, United States
View Trial Details
Active, not recruiting

Iberdomide-dexamethasone Alone or in Combination With Standard MM Treatment Regimens in Transplant Ineligible Newly Diagnosed Patients.

NCT05527340

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Hospital General Universitario Gregorio Marañón Madrid, Spain
  • Hospital Universitario 12 de Octubre Madrid, Spain
  • Hospital Son Llatzer Palma de Mallorca, Spain
  • Clínica Universidad de Navarra Pamplona, Spain
View Trial Details

Related conditions